Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders
Mostrando el original en inglés
Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders
Fase
No reportado
Inscripción
352 (estimado)
Rango de edad
13 Years to —
Sexo
ALL
Resumen
The primary objectives of this prospective mixed-method interview study are to use semi-structured interviews in parents of sickle cell disease (SCD) patients to describe parental attitudes of research involving genomic sequencing, including concerns about participation and expectations from researchers and second, to use surveys to quantitatively measure genetic/genomic knowledge, trust in health care provider, and literacy/numeracy ability in parents of children with SCD and adolescents with SCD. Secondary objectives are development of a web-based tool about treatment options for SCD that fosters patient-clinician communication and promotes shared decision-making. The web-based tool will undergo usability and pilot testing to ensure it is accessible to families and provide data about strategies for integrating into clinical conversations about treatment options. Investigators will use the data generated to reduce the risk of misunderstanding about DNA and genetic research and build strong relationships between SCD families and researchers in the future. The project will design educational information and study materials to help parents of children with SCD understand important details about genomic medicine in SCD care.
Mostrando el original en inglés
Afecciones estudiadas
Período de inscripción
17 dic 2020 – finalización estimada 26 mar 2024
Patrocinadores
Ubicaciones del estudio
St. Jude Children's Research Hospital
Memphis, Tennessee